CHL Hospitals - Clinical Research Department (CHL-CRD) was constituted in the year 2006, as envisioned by late Professor Dr. S. R. Jain, under the able leadership of top management of the institute. Research mission of CHL-CRD is to undertake and promote excellence in clinical research, foster and support patient care and treatment. At CHL-CRD, pharma-sponsored research projects provide the foundation for research activities. These projects are complemented by organizational projects, population-based epidemiology studies, community-based intervention programs, multi center controlled clinical trials, and research training programs.
Objective(s) of Research Department:
• Review sponsored (pharma-sponsored, govt-sponsored etc.) research proposals for feasibility and conduct at the Institute;
• Assist Investigators and provide complete support for initiation and in progress of scientific and clinical research projects;
• Coordinate the functioning of committees for research and ethics in CHL.
• Our site’s Clinical Research Department has been involved in phase II, III and IV research activities for more than a decade in indications such as cardiology, endocrinology (diabetes), oncology, critical care, dermatology, urology, pain, infections, gastroenterology, nephrology, orthopedics, etc;
• Experienced and GCP trained research investigators assisted by dedicated and full time GCP trained research team;
• Spacious working area with facilities for storage, audit and archival of research related activities;
• Updated SOPs in accordance with national and international regulations.
• NABL accredited full-fledged CHL-Laboratory. Our lab, CHL-Laboratory was the first NABL accredited in Madhya Pradesh for the subjects of clinical pathology, haematology, biochemistry, cytology and histopathology;
• NABH accredited CHL-Hospitals;
• CDSCO registered (ECR/505/Inst/MP/2014/RR-20) and Madhya Pradesh’s first NABH accredited Institutional Ethics Committee [EC- CT- 2018-0036; July 2021-2024].
• Department of Health Research (NAITIK): Provisional Registration - EC/NEW/INST/2020/487
All of the phases in clinical trials are governed by strict protocols, and are overseen by many regulatory bodies, from the Drug Controller General of India to Institutional Ethics Committee (IEC). IECs are a group comprising of independent medical experts, basic medical scientists, pharmacologist, legal experts, ethicist / philosopher / social worker / theologian, as well as lay person. Researchers periodically report to the IEC regarding entire conduct of the study which includes the tests involved in the study, the results recorded and even the side effects reported.